Immune effector cell-associated hematotoxicity: mechanisms, clinical manifestations, and management strategies
Chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment landscape for hematologic malignancies. However, it is frequently complicated by immune effector cell-associated hematotoxicity (ICAHT), a potentially life-threatening adverse event encompassing neutropenia, anemia, and th...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11947 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|